Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan

Peficitinib for the treatment of rheumatoid arthritis: an overview from clinical trials

(2020) Yoshiya Tanaka et al.   EXPERT OPINION ON PHARMACOTHERAPY

JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk

(2020) Puja Mehta et al.   EUROPEAN RESPIRATORY JOURNAL

Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia‐Pacific region: Post‐hoc analyses of pooled clinical study data

(2019) Eun Bong Lee et al.   International Journal of Rheumatic Diseases

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)

(2019) Yoshiya Tanaka et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan

(2019) Tsutomu Takeuchi et al.   ANNALS OF THE RHEUMATIC DISEASES

Upadacitinib: First Approval

(2019) Sean Duggan et al.   DRUGS

Safety of baricitinib in East Asian patients with moderate‐to‐severe active rheumatoid arthritis: An integrated analysis from clinical trials

(2019) Ying‐Chou Chen et al.   International Journal of Rheumatic Diseases

OUP accepted manuscript

(2018)   RHEUMATOLOGY

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

(2017) Kevin L. Winthrop et al.   Arthritis & Rheumatology

Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study

(2015) Tsutomu Takeuchi et al.   ANNALS OF THE RHEUMATIC DISEASES

Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis

(2014) Kevin L. Winthrop et al.   Arthritis & Rheumatology

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

The Japanese experience with biologic therapies for rheumatoid arthritis

(2010) Tsutomu Takeuchi et al.   Nature Reviews Rheumatology